Donor socioeconomic status may impact patient outcomes after HCT
Background
Methods
Results
Findings from this study suggest that SES has a biological impact that can affect how donor cells function in a new host environment. Key results include:
- Donor SES was significantly associated with recipient DFS.
- Patients transplanted from donors in the lowest SES quartile showed inferior DFS vs. donors from the highest SES quartile.
- Patients transplanted from donors in the lowest SES quartile experienced a 9.7% reduction in OS vs. patients transplanted from donors in the highest SES quartile.
- Patients transplanted from donors in the lowest SES quartile experienced a 6.6% increase in TRM within 3 years vs. those transplanted from donors in the highest SES quartile.
The researchers note that these results appear consistent with previous research linking socioeconomic disadvantage to altered immune cell function and hematopoiesis, revealing an unanticipated persistence of those effects after transplant.
Key takeaways
Future research with more contemporary datasets is needed to map the biological mechanisms involved in the social determinants of health and develop interventions to block those effects and enhance the health of both HCT recipients and donors.
These results are from a historical cohort receiving transplants over 10 years ago. Much has changed in the transplant field over the past decade, with advances in supportive care, improved donor selection and improvements in graft-versus-host disease prevention strategies. Whether the observed SES effects persist in the modern era is worthy of further exploration.
To overcome barriers in health equity and HCT access, NMDP has partnered with the American Society for Transplantation and Cellular Therapy (ASTCT) to launch ACCESS Initiative. Through awareness, practice change and policy work, this collaborative effort takes aim at these systemic challenges across the cell therapy and transplant ecosystem.
Figure
This figure shows differences in (A) OS (B) TRM (C) DFS and (D) relapse stratified by donor SES quartiles. All plots are adjusted for relevant clinical and demographic variables.
Turcotte L, et al., published in PNAS